All common p210 and p190 Bcr-abl variants can be targeted by RNA interference [3]

Leukemia

Volumn 19, Issue 2, 2005, Pages 290-292

  Wohlbold, L ^a   van der Kuip, H ^a   Moehring, A ^a   Granot, G ^b   Oren, M ^b   Vornlocher, H P ^c   Aulitzky, Walter E ^d  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c ALNYLAM PHARMACEUTICALS   (United States)

^d ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BAF15; BAF17; BAF19; BAF3; BCR ABL PROTEIN; GENE PRODUCT; MESSENGER RNA; PROTEIN P190; RETROVIRUS VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; BREAST CELL; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROPORATION; GENE EXPRESSION; GENE FUSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; RNA INTERFERENCE; RNA SEQUENCE; RNA TRANSLATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 13544275901     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403603     Document Type: Letter

References (10)

1. Novina CD, Sharp PA. The RNAi revolution. Nature 2004; 430: 161-164.
2. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 2003; 138: 819-830.
3. Wilda M, Fuchs U, Wossmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21: 5716-5724.
4. Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003; 101: 1566-1569.
5. Wohlbold L, van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003; 102: 2236-2239.
6. + chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. Oligonucleotides 2003; 13: 401-409.
7. Kronenwett R, Haas R, Sczakiel G. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes. J Mol Biol 1996; 259: 632-644.
8. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209-216.
9. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD, Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199-208.
10. Freier SM, Kierzek R, Jaeger JA, Sugimoto N, Caruthers MH, Neilson T et al. Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci USA 1986; 83: 9373-9377.